Emerging investigations on retatruded, a dual stimulant for incretin hormone and GIP, suggest encouraging results in addressing weight gain and type 2 glucose intolerance. Preliminary evidence from clinical experiments show considerable diminutions in body bulk and enhanced glucose levels. Furthe